The Austin Regional Clinic (ARC) has acquired a COVID-19 serological test that detects the body’s antibody immune response to the infection caused by the virus.
They are currently doing internal validation of the test to measure accuracy which should be completed within the next two weeks. At that time, a decision will be made whether to begin offering antibody immunity testing for COVID-19, based on validation data. This test is not recommended by the FDA for diagnostic purposes but it may be useful in confirming prior exposure and potential immunity to COVID-19.
At this time, ARC is uncertain if a positive antibody test means a person has immunity and for how long they may be protected.
PLEASE LOG IN FOR PREMIUM CONTENT. Our website requires visitors to log in to view the best local news.
Not yet a subscriber? Subscribe today!
